Ypsomed Holding AG (YPSN) - Net Assets

Latest as of September 2025: CHF807.19 Million CHF ≈ $1.02 Billion USD

Based on the latest financial reports, Ypsomed Holding AG (YPSN) has net assets worth CHF807.19 Million CHF (≈ $1.02 Billion USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CHF1.21 Billion ≈ $1.53 Billion USD) and total liabilities (CHF401.49 Million ≈ $507.59 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Ypsomed Holding AG (YPSN) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets CHF807.19 Million
% of Total Assets 66.78%
Annual Growth Rate 8.9%
5-Year Change 71.9%
10-Year Change 153.77%
Growth Volatility 595.01

Ypsomed Holding AG - Net Assets Trend (2002–2025)

This chart illustrates how Ypsomed Holding AG's net assets have evolved over time, based on quarterly financial data. Also explore YPSN current and non-current assets for the complete picture of this company's asset base.

Annual Net Assets for Ypsomed Holding AG (2002–2025)

The table below shows the annual net assets of Ypsomed Holding AG from 2002 to 2025. For live valuation and market cap data, see Ypsomed Holding AG market cap and net worth.

Year Net Assets Change
2025-03-31 CHF679.68 Million
≈ $859.31 Million		 +10.03%
2024-03-31 CHF617.73 Million
≈ $780.98 Million		 +9.85%
2023-03-31 CHF562.33 Million
≈ $710.94 Million		 +43.25%
2022-03-31 CHF392.54 Million
≈ $496.28 Million		 -0.72%
2021-03-31 CHF395.38 Million
≈ $499.87 Million		 +2.61%
2020-03-31 CHF385.35 Million
≈ $487.18 Million		 +1.73%
2019-03-31 CHF378.80 Million
≈ $478.91 Million		 +10.91%
2018-03-31 CHF341.54 Million
≈ $431.80 Million		 +13.17%
2017-03-31 CHF301.80 Million
≈ $381.55 Million		 +12.68%
2016-03-31 CHF267.84 Million
≈ $338.62 Million		 +11.30%
2015-03-31 CHF240.64 Million
≈ $304.23 Million		 +5.47%
2014-03-31 CHF228.16 Million
≈ $288.46 Million		 +4.96%
2013-03-31 CHF217.37 Million
≈ $274.82 Million		 -0.29%
2012-03-31 CHF218.00 Million
≈ $275.61 Million		 -59.48%
2011-03-31 CHF538.06 Million
≈ $680.25 Million		 +0.06%
2010-03-31 CHF537.74 Million
≈ $679.85 Million		 +23.04%
2009-03-31 CHF437.03 Million
≈ $552.53 Million		 +4.66%
2008-03-31 CHF417.58 Million
≈ $527.93 Million		 +7.06%
2007-03-31 CHF390.03 Million
≈ $493.10 Million		 -3.46%
2006-03-31 CHF404.01 Million
≈ $510.78 Million		 +13.11%
2005-03-31 CHF357.17 Million
≈ $451.56 Million		 +2916.66%
2004-03-31 CHF11.84 Million
≈ $14.97 Million		 -89.40%
2003-03-31 CHF111.68 Million
≈ $141.20 Million		 +16.85%
2002-03-31 CHF95.58 Million
≈ $120.84 Million		 --

Equity Component Analysis

This analysis shows how different components contribute to Ypsomed Holding AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 11083.1% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (March 2025)

Component Amount Percentage
Retained Earnings CHF645.93 Million 95.03%
Common Stock CHF193.14 Million 28.42%
Total Equity CHF679.68 Million 100.00%

Ypsomed Holding AG Competitors by Market Cap

The table below lists competitors of Ypsomed Holding AG ranked by their market capitalization.

Company Market Cap
Orion Corp
KO:271560
 $3.85 Billion
Jiangsu Goodwe Power Supply Technology Co Ltd
SHG:688390
 $3.85 Billion
Jiangsu Shemar Electric Co Ltd
SHG:603530
 $3.85 Billion
Motor Oil (Hellas) Corinth Refineries S.A
AT:MOH
 $3.85 Billion
Seaboard Corporation
NYSE MKT:SEB
 $3.85 Billion
Cadence Bancorp
NYSE:CADE
 $3.85 Billion
Jiangxi Hongdu Aviation Industry Co Ltd
SHG:600316
 $3.84 Billion
MDA Ltd
TO:MDA
 $3.84 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Ypsomed Holding AG's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 617,734,000 to 679,685,000, a change of 61,951,000 (10.0%).
  • Net income of 87,504,000 contributed positively to equity growth.
  • Dividend payments of 27,299,000 reduced retained earnings.
  • Share repurchases of 2,534,000 reduced equity.
  • New share issuances of 1,081,000 increased equity.
  • Other comprehensive income increased equity by 147,489,000.
  • Other factors decreased equity by 144,290,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income CHF87.50 Million +12.87%
Dividends Paid CHF27.30 Million -4.02%
Share Repurchases CHF2.53 Million -0.37%
Share Issuances CHF1.08 Million +0.16%
Other Comprehensive Income CHF147.49 Million +21.7%
Other Changes CHF-144.29 Million -21.23%
Total Change CHF- 10.03%

Book Value vs Market Value Analysis

This analysis compares Ypsomed Holding AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 5.48x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 32.22x to 5.48x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2002-03-31 CHF8.47 CHF273.00 x
2003-03-31 CHF44.55 CHF273.00 x
2004-03-31 CHF4.74 CHF273.00 x
2005-03-31 CHF31.67 CHF273.00 x
2006-03-31 CHF35.84 CHF273.00 x
2007-03-31 CHF34.63 CHF273.00 x
2008-03-31 CHF37.06 CHF273.00 x
2009-03-31 CHF38.82 CHF273.00 x
2010-03-31 CHF44.77 CHF273.00 x
2011-03-31 CHF42.50 CHF273.00 x
2012-03-31 CHF17.23 CHF273.00 x
2013-03-31 CHF17.18 CHF273.00 x
2014-03-31 CHF18.09 CHF273.00 x
2015-03-31 CHF19.06 CHF273.00 x
2016-03-31 CHF21.21 CHF273.00 x
2017-03-31 CHF23.93 CHF273.00 x
2018-03-31 CHF27.14 CHF273.00 x
2019-03-31 CHF30.06 CHF273.00 x
2020-03-31 CHF29.68 CHF273.00 x
2021-03-31 CHF31.25 CHF273.00 x
2022-03-31 CHF30.95 CHF273.00 x
2023-03-31 CHF41.91 CHF273.00 x
2024-03-31 CHF45.25 CHF273.00 x
2025-03-31 CHF49.78 CHF273.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Ypsomed Holding AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 12.87%
  • The company shows good efficiency in utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 11.68%
  • • Asset Turnover: 0.56x
  • • Equity Multiplier: 1.96x
  • Recent ROE (12.87%) is above the historical average (11.62%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2002 6.04% 5.74% 0.86x 1.23x CHF-3.78 Million
2003 10.80% 8.79% 0.96x 1.28x CHF892.70K
2004 97.89% 6.25% 0.37x 42.30x CHF10.41 Million
2005 10.97% 16.21% 0.37x 1.84x CHF3.48 Million
2006 13.77% 17.92% 0.47x 1.65x CHF15.25 Million
2007 0.70% 0.99% 0.45x 1.60x CHF-36.26 Million
2008 6.37% 9.25% 0.45x 1.53x CHF-15.17 Million
2009 5.99% 9.60% 0.43x 1.45x CHF-17.54 Million
2010 1.75% 3.71% 0.38x 1.23x CHF-44.35 Million
2011 0.97% 2.15% 0.36x 1.25x CHF-48.60 Million
2012 3.90% 3.42% 0.76x 1.50x CHF-13.30 Million
2013 0.76% 0.67% 0.72x 1.57x CHF-20.09 Million
2014 5.96% 4.93% 0.78x 1.55x CHF-9.21 Million
2015 8.06% 6.33% 0.85x 1.50x CHF-4.67 Million
2016 13.37% 10.63% 0.87x 1.45x CHF9.03 Million
2017 15.32% 11.87% 0.92x 1.40x CHF16.07 Million
2018 15.24% 11.17% 0.93x 1.46x CHF17.91 Million
2019 15.88% 13.25% 0.77x 1.55x CHF22.26 Million
2020 3.13% 2.98% 0.58x 1.81x CHF-25.78 Million
2021 1.47% 1.44% 0.56x 1.82x CHF-33.73 Million
2022 5.89% 4.97% 0.61x 1.93x CHF-16.15 Million
2023 9.12% 10.31% 0.58x 1.53x CHF-4.96 Million
2024 12.69% 14.29% 0.50x 1.78x CHF16.59 Million
2025 12.87% 11.68% 0.56x 1.96x CHF19.54 Million

Industry Comparison

This section compares Ypsomed Holding AG's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

  • Industry: Medical Instruments & Supplies
  • Average net assets among peers: $3,757,567,632
  • Average return on equity (ROE) among peers: 13.05%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Ypsomed Holding AG (YPSN) CHF807.19 Million 6.04% 0.50x $3.85 Billion
Alcon AG (ALC) $21.55 Billion 4.72% 0.41x $30.03 Billion
Coltene Holding AG (CLTN) $90.23 Million 9.12% 1.08x $292.50 Million
SKAN Group AG (SKAN) $86.87 Million 5.15% 0.02x $1.13 Billion
Straumann Holding AG (STMN) $623.50 Million 28.21% 0.52x $15.48 Billion
Tecan Group AG (TECN) $143.33 Million 9.74% 1.36x $1.72 Billion
IVF Hartmann Holding AG (VBSN) $48.48 Million 21.37% 0.47x $336.00 Million

About Ypsomed Holding AG

SW:YPSN Switzerland Medical Instruments & Supplies
Market Cap
$4.71 Billion
CHF3.73 Billion CHF
Market Cap Rank
#4249 Global
#62 in Switzerland
Share Price
CHF273.00
Change (1 day)
-0.73%
52-Week Range
CHF267.00 - CHF436.00
All Time High
CHF437.00
Categories
Companies in Switzerland Medical Instruments & Supplies
About

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable inje… Read more